Cover Image
市場調查報告書

齲齒的開發中產品分析

Dental Caries - Pipeline Review, H1 2014

出版商 Global Markets Direct 商品編碼 271841
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
齲齒的開發中產品分析 Dental Caries - Pipeline Review, H1 2014
出版日期: 2014年05月15日 內容資訊: 英文 36 Pages
簡介

齲齒或稱蛀牙。是由於病原菌的特殊細菌生成的酸,破壞牙齒的琺瑯質,再加上其下的象牙質層。主要的症狀為牙痛和敏感,齲洞,吃甜的東西和熱的/冷的東西時(輕或尖銳)疼痛等。主要的治療藥包含氟化物等。

本報告提供全球各國的蛀牙治療用的開發中產品的開發情形相關分析、開發中產品的開發、上市的最新趨勢,及臨床實驗各階段產品一覽,再加上主要企業簡介、主要藥物概要、最新的產業趨勢等調查,並將結果概述為以下內容。

目錄

簡介

  • 分析範圍

蛀牙概要

治療藥的開發

  • 蛀牙之開發中產品:概要
  • 蛀牙之開發中產品:比較分析

各企業開發中的蛀牙治療藥

開發中產品的概要

  • 臨床實驗階段的產品
  • 初期階段的產品

蛀牙治療藥:開發中產品一覽(各企業)

蛀牙治療藥的開發企業

  • Aphios Corporation
  • Oragenics, Inc.
  • C3 Jian, Inc
  • Ensoltek Co., Ltd.

蛀牙:治療藥的評估

  • 單劑治療藥的情況
  • 各標的
  • 各行動機制
  • 各投藥法
  • 各分子類型

藥物簡介

  • C-16G2
    • 產品概要
    • 功能機制
    • 研究開發(R&D)的發展情形
  • SMaRT置換療法
  • Asterias
  • Hesed-2000
  • 蛀牙的治療藥

蛀牙治療藥:開發中產品的最新趨勢

蛀牙治療藥:開發暫停的產品

蛀牙相關產品的開發里程碑

  • 值得注意的最新趨勢、新聞稿(共3件)

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC5004IDB

Global Markets Direct's, 'Dental Caries - Pipeline Review, H1 2014', provides an overview of the Dental Caries's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Dental Caries, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dental Caries and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Dental Caries
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Dental Caries and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Dental Caries products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Dental Caries pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Dental Caries
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Dental Caries pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Dental Caries Overview
  • Therapeutics Development
    • Pipeline Products for Dental Caries - Overview
    • Pipeline Products for Dental Caries - Comparative Analysis
  • Dental Caries - Therapeutics under Development by Companies
  • Dental Caries - Pipeline Products Glance
    • Clinical Stage Products
    • Early Stage Products
  • Dental Caries - Products under Development by Companies
  • Dental Caries - Companies Involved in Therapeutics Development
    • Aphios Corporation
    • Oragenics, Inc.
    • C3 Jian, Inc
    • Ensoltek Co., Ltd.
  • Dental Caries - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • C-16G2 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SMaRT Replacement Therapy - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Asterias - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-2000 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs for Dental Caries - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Dental Caries - Recent Pipeline Updates
  • Dental Caries - Dormant Projects
  • Dental Caries - Product Development Milestones
    • Featured News & Press Releases
      • Mar 07, 2014: C3 Jian Initiates Phase 2 Clinical Trial of Anti-Cavity Drug
      • Feb 19, 2013: C3 Jian Completes C16G2 Phase I Clinical Study Enrollment
      • May 24, 2012: C3 Jian Obtains FDA Acceptance Of Investigational New Drug Application
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Dental Caries, H1 2014
  • Number of Products under Development for Dental Caries - Comparative Analysis, H1 2014
  • Number of Products under Development by Companies, H1 2014
  • Comparative Analysis by Clinical Stage Development, H1 2014
  • Comparative Analysis by Early Stage Development, H1 2014
  • Products under Development by Companies, H1 2014
  • Dental Caries - Pipeline by Aphios Corporation, H1 2014
  • Dental Caries - Pipeline by Oragenics, Inc., H1 2014
  • Dental Caries - Pipeline by C3 Jian, Inc, H1 2014
  • Dental Caries - Pipeline by Ensoltek Co., Ltd., H1 2014
  • Assessment by Monotherapy Products, H1 2014
  • Number of Products by Stage and Target, H1 2014
  • Number of Products by Stage and Mechanism of Action, H1 2014
  • Number of Products by Stage and Route of Administration, H1 2014
  • Number of Products by Stage and Molecule Type, H1 2014
  • Dental Caries Therapeutics - Recent Pipeline Updates, H1 2014
  • Dental Caries - Dormant Projects, H1 2014

List of Figures

  • Number of Products under Development for Dental Caries, H1 2014
  • Number of Products under Development for Dental Caries - Comparative Analysis, H1 2014
  • Number of Products under Development by Companies, H1 2014
  • Comparative Analysis by Clinical Stage Development, H1 2014
  • Comparative Analysis by Early Stage Products, H1 2014
  • Assessment by Monotherapy Products, H1 2014
  • Number of Products by Top 10 Route of Administration, H1 2014
  • Number of Products by Stage and Top 10 Route of Administration, H1 2014
  • Number of Products by Top 10 Molecule Type, H1 2014
  • Number of Products by Stage and Top 10 Molecule Type, H1 2014
Back to Top